---
title: "Traffic‑Light Lifestyle Program in an Integrative Clinic: Real‑World Patient‑Reported Outcomes"
id: "medrxiv-15-real-world-outcomes-of-a-traffic-light-approach-to-lifestyle-modification-in"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-15-real-world-outcomes-of-a-traffic-light-approach-to-lifestyle-modification-in"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1?rss=1"
published_at: "2026-11-11T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Traffic‑Light Lifestyle Program in an Integrative Clinic: Real‑World Patient‑Reported Outcomes
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-15-real-world-outcomes-of-a-traffic-light-approach-to-lifestyle-modification-in
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1?rss=1)
- **Published At:** 2026-11-11T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Retrospective single‑arm cohort of patients first seen at an integrative outpatient clinic between February 2025 and 30 September 2026, with follow‑up through 4 November 2026. The clinic delivered a three‑component lifestyle package to all patients: a traffic‑light dietary guideline, a **Yoga** protocol, and a daily **four‑spice extract**. - The clinic used a 21‑item **Health Building Lifestyle Guideline** and a 7‑step COM‑B based clinical protocol; all patients were offered follow‑up and reinforcement by telephone. - Study dataset: 4,047 valid visit records from 1,737 unique patients (904 female; 833 male). Mean ages reported separately by sex in the source. - Of the 1,737 patients, 1,466 had a usable telephone contact and were called for feedback; 1,016 provided a definitive YES/NO response about symptom relief. Calls without definitive answers were excluded from per‑protocol analyses. - Primary patient conditions (counted as patient‑condition pairs) included **hypertension** (511 pairs), **obesity** (397), and **arthritis** (268); objective screening contributed 246 pairs (obesity 161, hypertension 39, anaemia 44, diabetes 2). - Patient‑reported relief among those with a definitive answer: 850/1,016 (83.7% [95% CI 81.3–85.8]) reported relief; 166 reported no relief. Relief was higher among revisit patients (87.2% revisit vs 80.8% single‑visit within the responding group). - Conservative, intention‑to‑call lower bound (classifying all non‑definitive responders as no relief) produced a relief rate of 58.0% overall (850/1,466). - Compliance in the responding cohort: **four‑spice extract** 77.1%, diet 83.3%, **Yoga** 81.2%. When non‑responders were counted as non‑compliant, conservative compliance estimates fell to ~53–58% across practices. - A graded association appeared: among responders, relief increased across a five‑level composite compliance dose from 5.2% at dose 0 to 98.2% at dose 4 (all three practices plus a repeat visit). - The study was uncontrolled and observational; all lifestyle components were delivered jointly alongside continuing pharmacotherapy. The authors noted that causality cannot be inferred and recommended prospective, controlled, disease‑specific studies. The efficacy of the **four‑spice extract** remains under study and is not a proven treatment according to the source.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=ALCBOlutiO6vlo2gZsH5g7VcSg0Vsrwvr1bphmNubxI-1794500334.1802728-1.2.1.1-mIHa3Sm05BlRAud02vZzKb3d9TRNX3OUEDuopWc8RIIgFJgjNaaeNzH_1.eB9MxU) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Real-World Outcomes of a Traffic-Light Approach to Lifestyle Modification in Chronic Disease: Evidence from an Integrative Health Clinic [ View ORCID Profile](http://orcid.org/0000-0001-8345-2640)Rakesh Sarwal, [ View ORCID Profile](http://orcid.org/0000-0003-4027-8560)Kalidas Dattatraya Chavan, [ View ORCID Profile](http://orcid.org/0000-0003-3125-6060)Jagadish C. Sharma, Rajesh Manocha doi: https://doi.org/10.64898/2026.11.10.26367386 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Rakesh Sarwal 1 ESIC Medical College and Hospital,Faridabad; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Rakesh%2BSarwal%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sarwal%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARakesh%2BSarwal%2B) * [ORCID record for Rakesh Sarwal](http://orcid.org/0000-0001-8345-2640 "Open in new tab") * For correspondence: sarwalr@gmail.com Kalidas Dattatraya Chavan 2 ESIC Medical College and Hospital; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kalidas%2BDattatraya%2BChavan%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Chavan%20KD&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKalidas%2BDattatraya%2BChavan%2B) * [ORCID record for Kalidas Dattatraya Chavan](http://orcid.org/0000-0003-4027-8560 "Open in new tab") Jagadish C. Sharma 3 ESIC Medical College and Hospital, Faridabad; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jagadish%2BC.%2BSharma%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sharma%20JC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJagadish%2BC.%2BSharma%2B) * [ORCID record for Jagadish C. Sharma](http://orcid.org/0000-0003-3125-6060 "Open in new tab") Rajesh Manocha 4 ESIC Medical College and Hsopital, Faridabad * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Rajesh%2BManocha%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Manocha%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARajesh%2BManocha%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1342503/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1342503/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1342503/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1342503/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1342503/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1342503/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract *Background*: Non-communicable diseases driven by unhealthy lifestyles are a growing and largely avoidable burden among industrial workers. Patient-level evidence on the effectiveness of structured lifestyle programmes delivered alongside standard care - such as a traffic-light dietary guideline, a Yoga protocol and a daily four-spice culinary extract - remains limited. The Integrative Health Clinic (IHC) at ESIC Medical College & Hospital, Faridabad, India, is a family-medicine-style outpatient clinic that follows the 21-item Health Building Lifestyle Guideline and delivers care through a 7-step COM-B-based protocol. We therefore estimated patient-reported relief and compliance with three lifestyle practices in patients attending the IHC. *Methods*: We conducted a retrospective single-arm cohort of patients first seen between February 2025 and 30 September 2026, with follow-up through 4 November 2026. All patients received the three-component lifestyle intervention (advice on spice extract, diet and Yoga) and were offered follow-up; the 1,466 patients with a usable telephone contact were called for feedback and reinforcement of practices. A physical visit with a coded diagnosis was treated as a valid record. Each patient called was coded once for relief and for spice, diet and Yoga compliance using the most recent definitive answer (YES/NO); calls without a definitive answer ("no response", "not interested") were skipped, and patients with no definitive answer on any call were classified as such. Disease burden, including the screening-detected diagnoses, was counted as patient-condition pairs and classed into 14 systems. *Results*: There were 4,047 valid visit records from 1,737 unique patients (904 female [52.0%]; mean age 40.3 +/- 14.6 years; 833 male [48.0%]; mean age 44.8 +/- 15.1 years). Of these, there were 1,035 single-visit [59.6%] and 702 revisit patients [40.4%], i.e. 2.33 visits per patient. The 1,466 analysed patients (763 female [52.1%] and 703 male [47.9%]) comprised 666 revisit and 800 single-visit patients. Their most frequent patient-condition pairs were hypertension (511), obesity (397) and arthritis (268); objective-evidence screening contributed 246 pairs in 233 patients (obesity 161, hypertension 39, anaemia 44, diabetes 2). Of the 1,466 (84.4% of 1,737) patients with a usable telephone contact who were called, 1,016 had a definitive relief answer: 850 (83.7%; 95% CI 81.3-85.8) reported relief and 166 reported no relief. The remaining 450 had no definitive answer. Among the 1,016 patients with a definitive answer, relief was 87.2% (395/453) in revisit versus 80.8% (455/563) in single-visit patients. Treating all 450 patients without a definitive relief answer as no relief, the conservative lower bound of patients reporting relief was 58.0% overall (850/1,466), 59.3% in revisit (395/666) and 56.9% in single-visit patients (455/800). Among the 1,016 patients with practice data, compliance with the spice extract, diet and Yoga was 77.1%, 83.3% and 81.2%, respectively; counting all 450 non-responders as non-compliant gave conservative estimates of 53.4%, 57.7% and 56.3% for the three practices (n = 1,466). In the responding cohort, relief rose with the five-level compliance dose, from 5.2% (6/115) at dose 0 to 98.2% (326/332) at dose 4 (all three practices plus a repeat visit). *Conclusions*: In this exploratory single-arm cohort, patient-reported relief was more frequent at higher levels of a composite measure that combined the three practices and repeat visits. Because there was no comparison group and all lifestyle components were delivered jointly alongside continuing pharmacotherapy, causality cannot be inferred. The findings support feasibility and justify prospective, controlled, disease-specific studies. The efficacy of the four-spice extract remains under study and is not yet a proven treatment. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethics committee of ESIC Medical College and Hospital, Faridabad, India (EC Reg Number:EC_NEW_INST_2023_HR_0307) gave ethical approval for this work I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Subject to the limitations imposed by the Ethics committee, all data produced in the present study are available upon reasonable request to the authors Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-ND 4.0 International license](http://creativecommons.org/licenses/by-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.10.26367720v1 "Spatiotemporal mapping of ex vivo myometrial contractions in adenomyosis")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.11.26367301v1 "Dysregulated B Cell Education Drives Autoimmunity and Immunodeficiency in Down Syndrome") Posted November 11, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/11/2026.11.10.26367386.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.11.10.26367386v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/11/2026.11.10.26367386.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Real-World Outcomes of a Traffic-Light Approach to Lifestyle Modification in Chronic Disease: Evidence from an Integrative Health Clinic Rakesh Sarwal, Kalidas Dattatraya Chavan, Jagadish C. Sharma, Rajesh Manocha medRxiv 2026.11.10.26367386; doi: https://doi.org/10.64898/2026.11.10.26367386 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.10.26367386v1%26text%3DReal-World%2520Outcomes%2520of%2520a%2520Traffic-Light%2520Approach%2520to%2520Lifestyle%2520Modification%2520in%2520Chronic%2520Disease%253A%2520Evidence%2520from%2520an%2520Integrative%2520Health%2520Clinic "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.10.26367386v1%26t%3DReal-World%2520Outcomes%2520of%2520a%2520Traffic-Light%2520Approach%2520to%2520Lifestyle%2520Modification%2520in%2520Chronic%2520Disease%253A%2520Evidence%2520from%2520an%2520Integrative%2520Health%2520Clinic "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.10.26367386v1%26title%3DReal-World%2520Outcomes%2520of%2520a%2520Traffic-Light%2520Approach%2520to%2520Lifestyle%2520Modification%2520in%2520Chronic%2520Disease%253A%2520Evidence%2520from%2520an%2520Integrative%2520Health%2520Clinic%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.10.26367386v1%26title%3DReal-World%2520Outcomes%2520of%2520a%2520Traffic-Light%2520Approach%2520to%2520Lifestyle%2520Modification%2520in%2520Chronic%2520Disease%253A%2520Evidence%2520from%2520an%2520Integrative%2520Health%2520Clinic "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.10.26367386) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.10.26367386v1&count=horizontal&via=&text=Real-World%20Outcomes%20of%20a%20Traffic-Light%20Approach%20to%20Lifestyle%20Modification%20in%20Chronic%20Disease%3A%20Evidence%20from%20an%20Integrative%20Health%20Clinic&counturl=www.medrxiv.org/content/10.64898/2026.11.10.26367386v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (638) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (921) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (352) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5017) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (429) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (679) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1696) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16282) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1242) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7292) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (753) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1095) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5304) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1475) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1836) * [Hematology](https://www.medrxiv.org/collection/hematology) (599) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1383) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16502) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1203) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (701) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (754) * [Neurology](https://www.medrxiv.org/collection/neurology) (7617) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1132) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1297) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1041) * [Oncology](https://www.medrxiv.org/collection/oncology) (3752) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1096) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (411) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (467) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (502) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (143) * [Pathology](https://www.medrxiv.org/collection/pathology) (722) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1864) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (757) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (787) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6153) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (10014) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2542) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitati
## Related Clinical Research

- [Cardiovascular risk and mortality after statin initiation: achieved LDL and non‑HDL levels in a 3‑](https://medichelpline.com/clinical-feed/plos-medicine-0-risk-of-cardiovascular-events-and-mortality-associated-with-ldl-and-non-hdl.md)
- [Election-related stress and the heart: links between elections, arrhythmias, and heart attacks](https://medichelpline.com/clinical-feed/stat-news-0-how-election-day-can-affect-your-heart.md)
- [Th17/Treg imbalance in psoriasis patients with metabolic dysfunction‑associated steatotic liver di](https://medichelpline.com/clinical-feed/frontiers-in-immunology-12-th17-treg-imbalance-and-clinical-characteristics-in-psoriasis-patients-with.md)
- [Hyperuricemia and Gout in People Living with HIV: Systematic Review and Meta-analysis Protocol](https://medichelpline.com/clinical-feed/plos-one-6-urate-dysregulation-hyperuricemia-and-gout-among-people-living-with-hiv-a.md)
- [Testosterone Therapy in Men Often Prescribed Inconsistently with Guidelines, ENDO 2026 Study Shows](https://medichelpline.com/clinical-feed/endocrine-news-0-video-testosterone-therapy-in-men-may-be-overprescribed-inconsistent-with.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.